Skip to main content
Elrexfio 76 mg/1.9mL injection, solution by Pfizer Laboratories Div Pfizer Inc
Elrexfio, 76 mg/1.9mL, injection, solution Available on prescription only. Listed by Pfizer Laboratories Div Pfizer Inc.
Prescription only

Elrexfio

elranatamab-bcmm

Listed by Pfizer Laboratories Div Pfizer Inc

Strength
76 mg/1.9mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Elranatamab 76 mg/1.9mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 0069-4494
FDA application BLA761345
RxNorm concept 2644885
Package sizes listed 1
Marketed since August 2023

Other products containing Elranatamab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Elrexfio

elranatamab-bcmm

Strength
44 mg/1.1mL
Form
Injection, Solution
Rx only

Pfizer Laboratories Div Pfizer Inc

Not stocked by us — reference only

Elrexfio

elranatamab-bcmm

Strength
44 mg/1.1mL
Form
Injection, Solution
Rx only

U.S. Pharmaceuticals

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.